Pharmacokinetic Evaluation of Coagulation Factor VIIa (Recombinant) in Subjects with Congenital Hemophilia A with or without Inhibitors to Factor VIII
Latest Information Update: 12 Mar 2022
At a glance
- Drugs Recombinant factor VIIa (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics
- Sponsors LFB
- 02 Feb 2022 Actual date of last participant enrolled is 28/07/2021 according to Australian New Zealand Clinical Trials Registry record.
- 02 Feb 2022 Status changed from not yet recruiting to completed.
- 06 Nov 2020 New trial record